Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Amgen
(NQ:
AMGN
)
312.47
-2.25 (-0.71%)
Streaming Delayed Price
Updated: 4:00 PM EDT, May 17, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Amgen
< Previous
1
2
...
29
30
31
32
33
34
35
36
37
...
40
41
Next >
What 10 Analyst Ratings Have To Say About Amgen
February 09, 2022
Analysts have provided the following ratings for Amgen (NASDAQ:AMGN) within the last quarter:
Via
Benzinga
10 Biggest Price Target Changes For Wednesday
February 09, 2022
Cowen & Co. cut the price target on Chipotle Mexican Grill, Inc. (NYSE: CMG) from $2,250 to $1,950. Chipotle shares rose 6.1% to $1,549.97 in pre-market trading.
Via
Benzinga
Dow Brushes Off Rising Bond Yields With Triple-Digit Win
February 08, 2022
Despite inflationary fears driving the 10-year Treasury note to its highest level since November 2019, stocks managed to walk away with wins on Tuesday.
Via
Talk Markets
AMD And Pinduoduo Lead The Nasdaq Higher
February 08, 2022
U.S. indices finished higher Tuesday as traders and investors weighed recent earnings and watch for inflation data later this week.
Via
Benzinga
What Are Whales Doing With Amgen
February 08, 2022
Someone with a lot of money to spend has taken a bearish stance on Amgen (NASDAQ:AMGN). And retail traders should know. We noticed this today when the big position showed up on publicly available...
Via
Benzinga
Amgen Stock Remains In Limbo As Its Biggest Product Flounders
February 07, 2022
Sales of Enbrel fell, in part, because Amgen's Otezla gained a new approval.
Via
Investor's Business Daily
Price To Earnings Ratio Insights For Amgen
February 03, 2022
Via
Benzinga
The Daily Biotech Pulse: Pfizer, Amgen Shares Slip On Earnings, Editas Terminates Chief Medical Officer, Biogen Licenses Preclinical Rheumatoid Arthritis Biosimilar
February 08, 2022
Here's a roundup of top developments in the biotech space over the last 24 hours:
Via
Benzinga
Amgen's Q4 Sales Remain Flat As Its Biggest Product Flounders
February 08, 2022
Amgen Inc's (NASDAQ: AMGN) Q4 revenues incr
Via
Benzinga
Failed Experiments
February 08, 2022
Amazon had around $470 billion in revenue in 2021. Was it worth it to pick up $14.5 billion in revenue in online grocery sales?
Via
Talk Markets
What's Going On With Amgen Stock During Today's After-Hours Session
February 07, 2022
Shares of Amgen Inc. (NASDAQ: AMGN) stepped higher following the release of its Q4 earnings report showing an EPS beat and a slight miss on sales. The company reported, on a GAAP...
Via
Benzinga
Amgen: Q4 Earnings Insights
February 07, 2022
Amgen (NASDAQ:AMGN) reported its Q4 earnings results on Monday, February 7, 2022 at 04:00 PM. Here's what investors need to know about the announcement. Earnings Amgen beat estimated earnings by 5.83%,...
Via
Benzinga
(AMGN) - Analyzing Amgen Inc's Short Interest
February 07, 2022
Amgen Inc's (NASDAQ:AMGN) short percent of float has risen 5.91% since last its last report. The company recently reported that it has 12.07 million shares sold short, which is 2....
Via
Benzinga
Picking Up Steam
February 07, 2022
Friday’s close marked 23 trading days since the S&P 500’s last closing record high, and during that span, the S&P 500 is down 6.2%.
Via
Talk Markets
A Peek Into The Markets: US Stock Futures Down; Crude Oil Falls Over 1%
February 07, 2022
U.S. stock futures traded lower in early pre-market trade after the Nasdaq jumped more than 200 points in the previous session.
Via
Talk Markets
A Peek Into The Markets: US Stock Futures Down; Crude Oil Falls Over 1%
February 07, 2022
Pre-open movers
Via
Benzinga
Earnings Scheduled For February 7, 2022
February 07, 2022
Companies Reporting Before The Bell • NAPCO Security (NASDAQ:NSSC) is expected to report quarterly earnings at $0.10 per share on revenue of $31.60 million.
Via
Benzinga
5 Stocks To Watch For February 7, 2022
February 07, 2022
Some of the stocks that may grab inve3stor focus today are: Wall Street expects Tyson Foods, Inc. (NYSE: TSN) to report quarterly earnings at $1.90 per share on revenue of $12.18 billion after the...
Via
Benzinga
The Week Ahead In Biotech (Feb. 6-12): Pfizer, AstraZeneca Earnings, Conference Presentations, IPOs And More
February 06, 2022
Biotech stocks managed to close the week ending Feb. 4 with gains. Stocks recovered along with the broader markets early in the week, but came under pressure midweek amid negative reaction to some big...
Via
Benzinga
A Preview Of Amgen's Earnings
February 04, 2022
Amgen (NASDAQ:AMGN) is set to give its latest quarterly earnings report on Monday, 2022-02-07. Here's what investors need to know before the announcement. Analysts estimate that Amgen will likely...
Via
Benzinga
Psoriasis Drug Providers Looking Over Shoulders At Upcoming Competitor?
February 03, 2022
Photo by Diana Polekhina on Unsplash
Via
Benzinga
Will Moderna Sidestep The Looming Sales Cliff After FDA Approves Covid Shot?
January 31, 2022
Currently, analysts expect Moderna sales to drop off after 2022.
Via
Investor's Business Daily
Dogs of the Dow Dominating
January 27, 2022
A little more than half of the Dogs are in the black year to date compared to only three (of twenty) non-dogs that are positive.
Via
Talk Markets
Say Hello to 2022’s Dogs of the Dow: 10 Dividend Stocks to Watch
January 27, 2022
As investor appetite for high-growth stocks begins to decrease in the new year, dividend stocks will likely to gain traction in 2022.
Via
InvestorPlace
Promising Results Continue to Develop Optimism in Fight Against Cancers
January 27, 2022
FN Media Group Presents USA News Group News Commentary Vancouver, BC –January 27, 2021 – USA News Group – There’s plenty of optimism surrounding the major medical breakthroughs targeting multiple types...
Via
FinancialNewsMedia
Is Amgen (AMGN) A Good Stock To Buy?
January 25, 2022
The pharmaceutical sector has a lot of big companies that pay a growing dividend, and AMGN is one of them.
Via
Talk Markets
CNBC's Final Trades: Marvell, Amgen, Viper Energy, JPMorgan And This Tech Major That Is 'Way Too Cheap'
January 25, 2022
On CNBC’s “Halftime Report Final T...
Via
Benzinga
A New Oral Therapy for Psoriasis Could Be Coming Soon
January 24, 2022
Photo by Towfiqu barbhuiya on Unsplash This post contains sponsored advertising content. This content is for informational purposes only and is not intended to be investing advice...
Via
Benzinga
14 Stocks in the Healthcare Sector
January 21, 2022
Here are 14 companies in the Healthcare Sector that have investment-grade credit ratings of BBB- or better, cash flow yield of 6% or better, future total return of at least 5%.
Via
Talk Markets
Amgen's Lumakras Approved In Japan For Pretreated Lung Cancer Patients
January 20, 2022
Amgen Inc's (NASDAQ: AMGN) Lumakras (sotorasib) has been approved in Japan for KRAS G12C-mutated positive, unresectable, advanced and/or recurrent non-small...
Via
Benzinga
< Previous
1
2
...
29
30
31
32
33
34
35
36
37
...
40
41
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.